Rivulet Media Inc Watch

from 8-K 3 pages Loan Agreement and Promissory Note

from 8-K 3 pages Loan Agreement and Promissory Note

from 8-K 6 pages Commercial Loan Agreement

from 10-12G 1 page Line of Credit Promissory Note

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of Four (4) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of Four (4)shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of Four (4) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of Four (4)shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 5 pages 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 5 pages 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 5 pages 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 5 pages 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 5 pages 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act